mycancervax.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: SemrushBot Disallow: / User-agent: SiteAuditBot Disallow: / User-agent: SemrushBot-BA Disallow: / User-agent: SemrushBot-SI Disallow: / User-agent: SemrushBot-SWA Disallow: / User-agent: SemrushBot-CT Disallow: / User-agent: SplitSignalBot Disallow: / User-agent: SemrushBot-COUB Disallow:
Meta Tags
Title mRNA UCV - My Cancer mRNA
Description OUR NOT AN OFFER TO INVEST. RED HERRING DISCLOSURE AVAILABLE ON REQUEST. PROFESSIONAL INVESTORS ONLY. Toggle Navigation Mission About MCV mRNA Vaccine Technol
Keywords N/A
Server Information
WebSite mycancervax faviconmycancervax.com
Host IP 52.54.172.46
Location United States
Related Websites
Site Rank
More to Explore
mycancervax.com Valuation
US$1,274
Last updated: 2023-05-18 05:58:54

mycancervax.com has Semrush global rank of 0. mycancervax.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. mycancervax.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 52.54.172.46. According to SiteAdvisor, mycancervax.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,274
Daily Ads Revenue US$1
Monthly Ads Revenue US$35
Yearly Ads Revenue US$423
Daily Unique Visitors 9
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
mycancervax.com. A 600 IP: 52.54.172.46
mycancervax.com. NS 3600 NS Record: ns10.domaincontrol.com.
mycancervax.com. NS 3600 NS Record: ns09.domaincontrol.com.
HtmlToTextCheckTime:2023-05-18 05:58:54
NOT AN OFFER TO INVEST. RED HERRING DISCLOSURE AVAILABLE ON REQUEST. PROFESSIONAL INVESTORS ONLY. Toggle Navigation Mission About MCV mRNA Vaccine Technology Cancer Therapy MCV Development MCV Manufacturing Normax Contact NOT AN OFFER TO INVEST. RED HERRING DISCLOSURE AVAILABLE ON REQUEST. PROFESSIONAL INVESTORS ONLY. Toggle Navigation Mission About MCV mRNA Vaccine Technology Cancer Therapy MCV Development MCV Manufacturing Normax Contact mRNA UCV sibiu162 2023-05-11T11:29:55+00:00 We specialize in rapid development of a unique Personalized mRNA Vaccine for Your Cancer OUR MISSION Our mission is to develop personalized cancer vaccines designed to direct the immune response of the patient to attack the specific cancer cells of the patient, based on a collection of neoantigens that have been linked with the specific cancer cells of the patient. MY CANCER mRNA VACCINE (MCV) IS PERSONALIZED TARGETED FOR YOU MCV investigational mRNA cancer vaccines will be manufactured for individuals
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 26 May 2022 17:13:37 GMT
Server: Apache/2.4.29 (Ubuntu)
Location: https://mycancervax.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 200 OK
Date: Thu, 26 May 2022 17:13:38 GMT
Server: Apache/2.4.29 (Ubuntu)
Link: ; rel="https://api.w.org/"
Link: ; rel="alternate"; type="application/json"
Link: ; rel=shortlink
X-TEC-API-VERSION: v1
X-TEC-API-ROOT: https://mycancervax.com/wp-json/tribe/events/v1/
X-TEC-API-ORIGIN: https://mycancervax.com
Content-Type: text/html; charset=UTF-8
mycancervax.com Whois Information
Domain Name: MYCANCERVAX.COM
Registry Domain ID: 2682281608_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2022-03-17T13:17:02Z
Creation Date: 2022-03-17T13:17:02Z
Registry Expiry Date: 2023-03-17T13:17:02Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS09.DOMAINCONTROL.COM
Name Server: NS10.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-26T17:39:24Z <<<